Concepedia

Michael Z. Hoemann

MZ

Statistics

Publications

12

Citations

378

H-Index

12

Active since

1995

Affiliations

University of Kansas(Current)

Sunovion (United States)

AbbVie (United States)

L'Oréal (France)

Michael Z. Hoemann is an author at University of Kansas specializing in medicinal chemistry, pharmacology, and drug discovery.

ORCID

Publications per year

1995–2022

12

Publications

12

Potent In vitro methicillin-resistant Staphylococcus aureus activity of 2-(1H-indol-3-yl)quinoline derivatives

Michael Z. Hoemann, G. Kumaravel, Roger L. Xie et al. · Bioorganic & Medicinal Chemistry Letters · 2000 · 69 citations

, , +11

Biological Properties of Novel Antistaphylococcal Quinoline-Indole Agents

B Oliva, Keith Miller, Nico Caggiano et al. · Antimicrobial Agents and Chemotherapy · 2003 · 58 citations · Full text

, , +17

Butitaxel Analogues:  Synthesis and Structure−Activity Relationships

Syed Mashhood Ali, Michael Z. Hoemann, Gunda I. Georg et al. · Journal of Medicinal Chemistry · 1997 · 42 citations

, , +13

Novel cytotoxic 3'-(tert-Butyl) 3'-diphenyl analogs of paclitaxel and docetaxel

Syed Mashhood Ali, Michael Z. Hoemann, Jeffrey Aubé et al. · Journal of Medicinal Chemistry · 1995 · 41 citations

, , +9

Potent In vitro methicillin-resistant Staphylococcus aureus activity of 2-(1H-indol-3-yl)tetrahydroquinoline derivatives

Michael Z. Hoemann, Roger L. Xie, Richard F. Rossi et al. · Bioorganic & Medicinal Chemistry Letters · 2002 · 41 citations

, , +13

1–5 of 12